About Sunrest Lifescience Limited
Sunrest Lifescience Limited is launching its IPO. The offer opens for subscription on 07th November 2023 and will close on November 09th, 2023.
Disclaimer: This stock will trade with a lot size of 1600 shares in the SME segment on listing.
What does Sunrest Lifescience Limited do?
The Indian pharmaceutical industry ranks third in the world by volume and is well known for producing affordable vaccinations and generic medicines. Generic medications, over-the-counter medications, bulk medications, vaccines, contract research and manufacturing, biosimilars, and biologics are some of the main sectors of the Indian pharmaceutical industry.
Originally called “Sunrest Lifescience Private Limited,” the company was established on October 30, 2017, per the 2013 Companies Act. It then changed its name to “Sunrest Lifescience Limited” and became a public limited company on March 9, 2023. The company’s Corporate Identification Number is U74999GJ2017PLC099606, and it is headquartered in Ahmedabad.
The promoters of the company are Mr. Bharatkumar V Thakkar, Mr. Bhagyesh Kiritbhai Parekh, Mr. Amitbhai Shambhulal Thakkar, and Mr. Nikhilkumar Y Thakkar, who collectively have over two decades of experience in the pharmaceutical industry.
Sunrest Lifescience Limited’s area of expertise is selling generic pharmaceuticals over-the-counter (OTC) in the home market. They operate in several Indian states and provide a variety of medicinal items made by outside businesses. Capsules, tablets, syrups, ointments, gels, mouthwash, suspensions, solutions, dry powders, and toothpaste are among their product offerings. They provide a large selection of medications, which include treatments for diabetes, dental problems, allergies, hypertension, and inflammation, in addition to those for bacterial, fungal, and parasitic illnesses.
Sunrest Lifescience Limited holds 18 registered trademarks for 32 products. The products are distributed to stockists and super stockists and are made available in chemist shops, dispensaries, hospitals, etc. The company’s operations are supported by various third-party manufacturers. They typically work on a third-party manufacturing basis or, occasionally, through purchase orders with pharmaceutical product manufacturers, depending on customer requirements.
Schedule/Timeline of Sunrest Lifescience Limited IPO
| Issue Period | November 07, 2023 to November 09, 2023 |
| Price band | ₹84 per share |
| Finalization of Allotment | November 15, 2023 |
| Initiation of Refunds | November 16, 2023 |
| Credit of Shares | November 17, 2023 |
| Date of Listing | November 20, 2023 |
| Mandate end date | November 24, 2023 |
| Anchor Investors Lock-In End Date | December 09, 2023 |
How to apply to the Sunrest Lifescience Limited IPO?
You can apply for the Sunrest Lifescience Limited IPO using any supported UPI app by following two steps:
- Enter your bid on Kite
- Accept the UPI mandate on your phone
On acceptance of the mandate, the bid amount will get blocked in your bank account. Click here to learn more.
How to check the allotment status for Sunrest Lifescience Limited IPO?
You can check the allotment status for the Sunrest Lifescience Limited IPO on the website of the Registrar and Transfer agent. Alternatively, you can also check the allotment status on the NSE website.